ISRCTN80111329已完成未知
A randomised double-blind trial of upward progressive versus degressive compressive stocking in patients with moderate to severe chronic venous insufficiency
Pierre Fabre (France)0 个研究点目标入组 400 人开始时间: 2012年1月3日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 400
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Male or female adult outpatients
- •2. Presenting current pain and/or heavy legs due to moderate to severe chronic venous insufficiency (CEAP C2b to C5)
- •3. Eligible for a 30 mmHg compressive therapy
排除标准
- •1. Bandage therapy recommended
- •2. Current use of a compressive stocking >30 mmHg
- •3. Active ulcer
- •4. Deep vein thrombosis or pulmonary embolism in the past three months
- •5. Arterial disease of the lower limb
- •6. Non-venous oedema
- •7. Inflammatory, dermatologic or traumatic disorder of a lower limb
- •8. Known hypersensitivity to components of the study compressive stockings
- •9. Surgery or vascular procedure in the past month or planned in the next three months
- •10. Poor life expectancy
- •11. Inability to walk
- •12. Pregnancy
研究者
相似试验
进行中（未招募）
1 期
A randomised, double-blind, prospective study to compare the analgesic efficacy of 10 ml epidural loading dose levobupivacaine 0.5% versus levobupivacaine 0.25% in patients after major abdominal or thoracic surgery.patient controlled epidural pain therapy after major abdominal or thoracic surgeryEUCTR2007-000700-32-BEniversity hospitals Leuven100
尚未招募
3 期
A comparative study to assess the effect of interventions to prevent lung damage during anaesthesia, on postoperative lung complications after lung cancer surgery.CTRI/2023/10/058887Tata Memorial Hospital Mumbai India
已完成
不适用
aparoscopic cholecystectomy: 5-mm versus 3-mm portsAcute pancreatitisSymptomatic gallstone disease including pancreatitisDigestive SystemISRCTN33058794orfolk and Norwich University Hospitals NHS Foundation Trust (UK)100
进行中（未招募）
1 期
Development of read-outs in healthy, hepatitis B virus naive adults vaccinated with the hepatitis B surface antigen (HBsAg) in combination with a GlaxoSmithKline (GSK) Biologicals’ Adjuvant System.Healthy volunteers (Hepatitis B surface antigen (HBsAg) vaccine administered in hepatitis B virus (HBV) naive adult subjects aged between 18 and 45 years old, inclusive, in good general health.)EUCTR2012-001344-22-BEGlaxoSmithKline Biologicals
进行中（未招募）
不适用
sefulness and safety of Mw vaccine versus Mantoux antigen in patients of warts caused by virusCTRI/2017/08/009327Medical College Kolkata